Dabrafenib plus trametinib candidates for standard-of-care in BRAF V600-mutated paediatric low-grade glioma
- 5 August 2022
- conference paper
- conference paper
- Published by Medicom Medische Uitgeverij BV in Medicom Conference Report ASCO 2022
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018Neuro-Oncology, 2021
- Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade GliomasJournal of Clinical Oncology, 2017